Ian F. Smith's Insider Trades & SAST Disclosures
Ian F. Smith's most recent trade in Stoke Therapeutics Inc was a trade of 238,420 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ian F. Smith.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Ian F. Smith | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 238,420 | 238,420 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 22,148 | 22,148 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 18,293 | 18,293 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 3,255 | 112,972 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 3,255 | 0 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 3,255 | 3,255 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 3,255 | 109,717 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 3,255 | 106,462 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 3,255 | 6,510 | - | - | Restricted Stock Units | |
| Foghorn Therapeutics Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 7,639 | 7,639 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 3,256 | 103,207 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 3,256 | 9,765 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 15,570 | 0 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Smith F. Ian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 15,570 | 99,948 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | F. Smith Ian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 15,112 | 15,112 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | F. Ian Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 13,021 | 13,021 | - | - | Restricted Stock Units | |
| Foghorn Therapeutics Inc | Smith Ian F. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 26,977 | 26,977 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 15,570 | 31,139 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 15,570 | 68,809 (0%) | 0% | - | Common Stock | |
| Foghorn Therapeutics Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 15,569 | 53,239 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 15,569 | 46,709 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 70,796 | 70,796 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 62,278 | 62,278 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,620 | 0 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,620 | 37,670 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 13,172 | 356,380 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 24,312 | 24,312 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 24,312 | 343,208 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2022 | 24,313 | 318,896 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2022 | 24,313 | 48,624 | - | - | Restricted Stock Units | |
| Foghorn Therapeutics Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 24,313 | 72,937 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ian F. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 24,313 | 294,583 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 194,500 | 194,500 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 97,250 | 97,250 | - | - | Restricted Stock Units | |
| Foghorn Therapeutics Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,530 | 12,530 | - | - | Stock Options (Right to buy) | |
| Foghorn Therapeutics Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 25,060 | 25,060 | - | - | Stock Options (Right to buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 389,000 | 389,000 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 270,270 | 270,270 (0%) | 0% | 3.7 | 999,999 | Common Stock |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 200,000 | 200,000 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Ian F. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2020 | 40,000 | 40,000 | - | - | Director Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges